Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives.
Saved in:
| Title: | Author Correction: Management of patients with advanced-stage HER2-positive breast cancer: current evidence and future perspectives. |
|---|---|
| Authors: | Marra A; Division of New Drugs and Early Drug Development, European Institute of Oncology IRCCS, Milan, Italy., Chandarlapaty S; Human Oncology and Pathogenesis Program (HOPP), Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Weill Cornell Medical College, New York, NY, USA., Modi S; Breast Medicine Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA. modis@mskcc.org.; Weill Cornell Medical College, New York, NY, USA. modis@mskcc.org. |
| Source: | Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2024 Sep; Vol. 21 (9), pp. 701. |
| Publication Type: | Published Erratum |
| Journal Info: | Publisher: Nature Pub. Group Country of Publication: England NLM ID: 101500077 Publication Model: Print Cited Medium: Internet ISSN: 1759-4782 (Electronic) Linking ISSN: 17594774 NLM ISO Abbreviation: Nat Rev Clin Oncol Subsets: MEDLINE; PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1759-4782 |
|---|---|
| DOI: | 10.1038/s41571-024-00933-8 |
